General Information of the Compound
Compound ID
CP0560395
Compound Name
3-(2,1,3-benzoxadiazol-5-yl)-1-benzylquinoxalin-2-one
    Show/Hide
Structure
Formula
C21H14N4O2
Molecular Weight
354.369
Canonical SMILES
O=c1c(nc2ccccc2n1Cc1ccccc1)-c1ccc2nonc2c1
    Show/Hide
InChI
InChI=1S/C21H14N4O2/c26-21-20(15-10-11-16-18(12-15)24-27-23-16)22-17-8-4-5-9-19(17)25(21)13-14-6-2-1-3-7-14/h1-12H,13H2
    Show/Hide
InChIKey
AONZDBAHWUYXHT-UHFFFAOYSA-N
Physicochemical Property
logP
3.648
Rotatable Bonds
3
Heavy Atom Count
27
Polar Areas
73.81
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 129286569
ChEMBL ID
CHEMBL4097026
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000259 FRT Rattus norvegicus (Rat)  1
1
EC50 = 18 nM
   TI
   LI
   LO
   TS